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Abstract
Objective: To determine the need for routine speciation of positive Lowenstein-Jensen mycobacterial cultures in HIV-
infected patients suspected of having pulmonary tuberculosis at Mulago Hospital in Kampala, Uganda.
Methods: Sputum and bronchoalveolar lavage Lowenstein-Jensen mycobacterial culture isolates from consecutive, HIV-
infected patients admitted to Mulago Hospital with 2 weeks or more of cough were subjected to IS6110 PCR and rpoB
genetic analysis to determine the presence of Mycobacterium tuberculosis complex (MTBC) and non-tuberculous
mycobacteria (NTM).
Results: Eighty (100%) mycobacterial cultures from 65 patients were confirmed to be members of MTBC. Subsequent
analysis of the cultures from 54 patients by PCR and sequence analyses to identify co-infection with NTM confirmed the
presence of MTBC as well as the presence of Micrococcus luteus (n=4), Janibacter spp. (n=1) and six cultures had organisms
that could not be identified.
Conclusions: Presumptive diagnosis of tuberculosis on the basis of a positive Lowenstein-Jensen culture is sufficient in HIV-
infected Ugandans suspected of having tuberculosis. Routine molecular confirmation of positive Lowenstein-Jensen
cultures is unnecessary in this low resource setting.
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Introduction
In sub-Saharan Africa, patients with cough greater than two
weeks who have positive sputum acid-fast bacilli (AFB) smear
examinations or positive sputum mycobacterial cultures are
usually diagnosed with pulmonary tuberculosis (TB). Speciation
of culture isolates by nucleic acid amplification or biochemical
techniques is rarely performed. However, pulmonary disease may
also be due to non-tuberculous mycobacteria (NTM), particularly
in HIV-infected patients. Several recent studies from sub-Saharan
Africa suggest the prevalence of NTM disease may be higher than
previously recognized [1–4]. One study has also reported isolating
NTM species from water and soil in Uganda [5]. Given the
increased risk of NTM lung disease in HIV-infected patients and
the possibility of culture contamination by environmental
mycobacteria, rapid speciation assays that distinguish NTM from
Mycobacterium tuberculosis complex (MTBC) could improve the
specificity of mycobacterial culture for TB diagnosis. However,
such assays increase costs and increase the workload of already
over-extended mycobacterial laboratories in high-burden coun-
tries. To determine whether routine speciation of positive Low-
enstein-Jensen (LJ) cultures is necessary in a population at high risk
for NTM disease, we performed PCR targeting the insertion
sequence (IS) 6110 and RNA polymerase b-subunit-encoding
(rpoB) genes on all available mycobacterial cultures collected from
a hospital-based sample of HIV-infected patients with TB. [6–8]
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Study Population and Patient Evaluation
We included all mycobacterial cultures isolated between April
and August 2007 from a hospital-based study of HIV-infected
patients. Briefly, consecutive HIV-infected adults admitted to the
medical wards of Mulago Hospital in Kampala with cough of two
weeks or more were included in the study. All individuals
submitted one spot and one early morning sputum specimen for
AFB smear and mycobacterial culture. If initial sputum smears
were AFB negative, patients were referred for bronchoscopy with
airway inspection for tracheobronchial lesions of Kaposi’s sarcoma
and bronchoalveolar lavage (BAL) fluid examination for myco-
bacteria (AFB smear and culture), Pneumocystis jirovecii (modified
Giemsa stain), and other fungi (potassium hydroxide smear and
culture).
Specimen Processing
All sputum and BAL fluid specimens were processed at the
Uganda National Tuberculosis Reference Laboratory (NTRL)
using standardized methods for digestion and decontaminated
using 1% N-acetyl-L-cysteine (NALC), 2% sodium hydroxide
(NaOH), and 2% sodium citrate solution. The resulting pellets
were inoculated on two LJ slants per sample and incubated at
37uC. NTRL technicians stored all cultures positive for mycobac-
teria (confirmed by Ziehl-Neelsen staining) in liquid culture media
(equal proportions of 25% glycerol and Middlebrook 7H9) and
stored them at 280uC until shipping. A subset of 57 cultures that
was successfully stored was sent to the Mycobacterium tuberculosis
Research Laboratory (MTBRL) at the University of California
San Francisco for PCR-based and gene-sequence analyses. At
MTBRL, cells were sub-cultured in LJ slants, Middlebrook 7H9
broth, and/or Middlebrook 7H11 agar, and incubated at 37uC.
DNA was extracted using a standardized method of heat
inactivation and/or cetyl-trimethylammonium bromide (CTAB)/
Chloroform Isoamyl Alcohol [9–10].
Identification of MTB complex
Initial speciation of mycobacterial culture isolates was done
using IS6110 PCR at the Makerere University Department of
Microbiology. Briefly, DNA was extracted from thawed frozen
culture isolates using thermolysis. IS6110 PCR was performed
using primers described by Muhumuza et al. [11]. IS6110 is a non-
coding region specific for MTB, and the presence of a 521-base-
pair band in the gel electrophoresis was considered compatible
with MTBC. For a subset of 57 isolates available for additional
analyses, IS6110 PCR analysis using a second set of primers [10]
was performed at the MTBRL. The presence of a 245 base-pair
fragment was considered positive for MTBC.
Identification of NTM
We used primer-specific amplification within the rpoB gene
(primers have a sequence unique for either MTBC or NTM at the
39 end of each primer) in 55 of the 57 cultures sent to the MTBRL
to differentiate between MTBC and NTM [7]. rpoB encodes the
RNA polymerase b-subunit and contains single nucleotide
polymorphisms that can be used to differentiate among mycobac-
terial species. The primers for MTBC were Tbc1 (59-
CGTACGGTCGGGGAGCTGATCCAA-39) and TbcR5 (59-
CCACCAGTCGGCGCTTGTGGGTCAA-39), and the primers
for NTM were M5 (59-GGAGCGGATGACCACCCAG-
GACGTC-39) and RM3 (59-CAGCGGGTTGTTCTGGTC-
CATGAAC-39). Briefly, 10 pM of Tbc1 and TbcR5 primers, 20
pM of M5 and RM3 primers and 1–5 ml of DNA were added to
FailSafe PCR 26 PreMix B (Epicentre, Madison, WI) and/or
AccuPower PCR PreMix (Bioneer, Daejeon, Korea) and PCR was
performed with the following parameters: initial denaturation at
95uC for 5 min, 30 cycles of amplification (at 95uC for 30 sec, then
at 72uC for 60 sec), and final elongation at 72uC for 5 min. PCR
products were analyzed by agarose gel electrophoresis (1%). In all
PCR reactions, Mycobacterium tuberculosis (M.TB) H37Rv DNA was
used as a positive control for MTBC, and M. fortuitum (ATCC
6841) or M. kansasii (ATCC 12478) DNA was used as a positive
control for NTM.
PCR products with a size of 136 bp (suggestive of NTM) were
purified and sequenced to confirm and identify the species of
NTM. The sequence reaction was performed using NTM-specific
primers RM3 and M5, and products were sequenced at the UCSF
Genomic Core Facility using ABI Big-Dye v3.1 dye terminator
sequencing chemistry (Applied Biosystems, Carlsbad, CA) and the
ABI PRISM 37306l capillary DNA analyzer. Sequence data was
analyzed using ApE v1.17 and basic local alignment search was
performed using National Center for Biotechnology Information
(NCBI)’s genomic Basic Local Alignment Search Tool (BLAST)
(http://blast.ncbi.nlm.nih.gov/Blast.cgi).
Microscopy
Kinyoun and Gram stain (BD, Franklin Lakes, NJ) slides were
prepared for isolates that were rpoB PCR positive for the 136-bp
fragment (suggestive of NTM).
Definitions
We considered mycobacterial cultures to contain MTBC if the
IS6110 PCR resulted in a product compatible with an IS6110
element or if rpoB PCR resulted in a product of 235 bp. We
considered mycobacterial cultures to contain NTM if rpoB PCR
resulted in a product of 136 bp and the sequence analysis results
were compatible with NTM species. If rpoB PCR resulted in a 136-
bp product but sequencing results were unavailable or inconclu-
sive, or if direct microscopy showed multiple organisms including
AFB, we considered mycobacterial cultures to possibly contain
NTM.
Statistical analysis
We summarized demographic characteristics of the study
population as medians and frequencies, and compared demo-
graphic and clinical characteristics using Fisher’s exact test for
categorical variables and Mann-Whitney rank-sum test for
continuous variables. We defined our threshold for statistical
significance as p,0.05. We used STATA 10.0 (Stata Corporation,
College Station, Texas, USA) for all statistical analyses.
Ethical considerations
The Makerere University Faculty of Medicine Research Ethics
Committee, the Mulago Hospital Institutional Review Board, the
Committee on Human Research at the University of California,
San Francisco Committee on Human Research, and the Uganda
National Council for Science and Technology approved the study
protocol. All study participants provided written informed consent.
Results
Study population
We included 80 mycobacterial cultures from 65 consecutive
HIV-positive patients (Figure 1.), with median CD4+ T-lympho-
cyte count of 30 cells/mL (inter-quartile range (IQR), 10-106 cells/
mL). Patients were predominantly male (54%), and the median age
was 33 years (IQR, 28–39 years). Of the 80 culture isolates, 75
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significant differences in demographic or clinical characteristics
between the 54 patients who had mycobacterial culture isolates
(N=55 isolates) tested at MTBRL and the 11 patients for whom
mycobacterial culture isolates (N=25 isolates) were unavailable
for further analysis.
MTBC detection
IS6110 PCR performed at the Makerere University Department
of Microbiology resulted in a 521 base-pair product in all 80
isolates, indicating that all the cultures contained MTBC. Of the
80 culture isolates, 57 were available for further analysis at
MTBRL and 55 were successfully sub-cultured. The presence of
MTBC was confirmed in 52 (95%) of 55 cultures either by
amplification of the IS6110 product (50 isolates), and/or by
amplification of a 235-bp product from the rpoB gene target (34
isolates) (Figure 1.). In three cultures, PCR amplification did not
produce any product of any size despite several attempts.
NTM detection
Of the 52 cultures with MTBC, 11 also had an rpoB PCR
product of 136-bp suggestive of NTM. Smears were prepared
from 10 of the 11 cultures for microscopic examination (the
culture for one was not available at the time of the slide
preparation). Kinyoun staining showed that all 10 cultures
contained AFB-positive organisms as well as other organisms
(Table 1.). Sequencing of the rpoB gene showed 4 matches with
Micrococcus luteus, 1 with Janibacter spp. (Figure 1. Table 1.), and two
that did not match with any organism, probably due to the
presence of two or more organisms. The other 4 isolates showed
products of 136 bp and 235 bp in the initial PCR suggesting the
presence of NTM and MTBC (the negative control of the PCR
showed no contamination). However, when PCR was repeated for
sequencing analysis, we were not able to amplify the 136 bp
product, possibly due to the low concentration of 136 bp specific
DNA relative to the 235 bp specific DNA, despite multiple
attempts.
Figure 1. PCR and sequencing results to determine the presence of NTM. Of the 52 isolates with valid PCR results, all were positive for MTBC
and 11 (21%) isolates had an rpoB PCR product suggestive of NTM. The sequence result showed that 4 of the 11 were compatible with Micrococcus
luteus and 1 with Janibacter sp, the remaining 6 (55%) did not have sequence results available. No NTM species were found.
doi:10.1371/journal.pone.0027017.g001
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The 11 cultures shown to have MTBC plus other organisms
belonged to 11 patients. The demographic and clinical character-
istics of these patients were similar to the 41 patients who had a
pure culture of MTBC (Table 2.). Of the 52 patients, 49 (94%) had
vital status ascertained two months after admission: 10 of 11 from
the patients who had MTBC plus other organisms, and 39 of 41
from the patients with pure MTBC growth. Survival at 2 months
was similar among these two groups of patients. Death occurred in
2/10 (20%) of the patients with a growth of MTBC plus other
organisms and in 8/39 (21%) patients with pure MTBC growth.
Discussion
In this study, we examined the specificity of Lowenstein-Jensen
culture for the diagnosis of TB using respiratory specimens
obtained from hospitalized, HIV-infected patients in Uganda
suspected to have pulmonary TB. We found that the 80 cultures
that grew mycobacteria all had positive molecular tests for MTBC
(100% specificity of LJ cultures for diagnosing TB). Interestingly,
further examination of 11 of 52 cultures showed the presence of
another organism, either by molecular techniques including PCR
and sequencing, or by smear examination. In six cultures, we
could not definitively rule out the presence of NTM; however, all
had MTBC. This finding suggests that routine molecular testing of
positive LJ cultures is not needed to define the presence of MTBC,
because all of the patients in this sample of HIV patients with
cough of two weeks or more seeking medical attention in Mulago
Hospital had TB.
Rapid speciation assays to confirm the presence of MTBC and
rule out NTM have been recently introduced. Despite limited
data, the WHO has recommended that such assays be routinely
used to confirm the presence of MTBC in all positive results
obtained from liquid culture systems [12]. One such rapid test is
the Capilia TB assay, a lateral-flow immunochromatographic
assay that detects the MPT64 antigen in MTBC culture isolates.
This test is comparable in performance to conventional biochem-
ical assays for confirmation of MTBC and significantly cheaper
Table 1. Molecular and microscopy results for the 11 isolates with MTBC and other organisms.
Isolate rpoB PCR IS6110 PCR Sequence results Kinyoun stain Gram stain
1 136 bp and 235 bp + Janibacter sp.A F B + Gram+ bacilli
2 136 bp + M. luteus AFB+ Gram+ bacilli
3 136 bp + M. luteus AFB+ Gram+ bacilli
4 136 bp and 235 bp + M. luteus AFB+ Gram+ bacilli
5 136 bp and 235 bp + N/A AFB+ Gram+ cocci
6 136 bp and 235 bp + N/A AFB+ Gram+ bacilli and cocci Gram- cocci
7 136 bp and 235 bp + N/A AFB+ Gram2 bacilli
8 136 bp and 235 bp + N/A AFB+ Gram2 bacilli, Gram variable bacilli
9 136 bp and 235 bp + N/A AFB+ Gram+ bacilli
10 136 bp and 235 bp + N/A AFB+ Gram+ cocci, Gram- cocci
11 136 bp and 235 bp + M. luteus N/A N/A
doi:10.1371/journal.pone.0027017.t001
Table 2. Demographic and Clinical Characteristics of patients by culture growth of MTB with or without other organisms.
Characteristic MTB only MTB plus other growth p-value
(N=41) (N=11)
Female (%) 19 (46) 6 (55) 0.74
Median age (IQR) 32 (28–39) 36 (31–39) 0.38
Current/Prior Smoker (%) 14 (34) 4 (36) 1.00
Symptoms
Fever (%) 40 (98) 11 (100) 1.00
Hemoptysis* (%) 7 (18) 0(0) 0.58
Weight loss (%) 39 (95) 9 (82) 0.19
Shortness of breath (%) 24 (59) 8 (73) 0.50
Cough (%) 41 (100) 11 (100) -
Chest pain (%) 24 (59) 7(64) 1.00
Anti-retroviral therapy* (%) 6 (24) 1 (13) 0.65
Co-trimoxazole prophylaxis* (%) 22 (88) 7 (88) 1.00
Median CD4 count* (IQR) 48 (12–152) 15 (9–68) 0.14
*Had missing values.
doi:10.1371/journal.pone.0027017.t002
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species from respiratory specimens have shown variable results. An
early study from Uganda reported the absence of NTM disease in
blood cultures of severely ill Ugandan HIV-infected patients with
AIDS [14]. However, in other parts of the continent, the
frequency of NTM isolation is considerably higher. In Ghana,
23% of patients with bronchopulmonary symptoms longer than
four weeks had NTM isolated from LJ cultures of respiratory
specimens [15]. However, the HIV serostatus of these patients was
not reported while colony appearances and biochemical tests were
used to identify NTM. Similarly, studies from South Africa
describe NTM as a frequent isolate from LJ cultures of sputum
samples from miners (incidence 47.6 per 100,000 person-years)
and from HIV-infected populations [2]. In a study from
Mozambique, Nunes et al. found NTM in 3 (1%) out of 277
isolates grown from LJ cultures of sputum or BAL samples of
patients who were HIV positive [16]. The frequency of patients
with cultures positive for both M.TB and NTM varies also
depending on the population and the region studied. In India, 2%
of 6,143 AFB-positive cultures were identified as NTM based on
speciation by rpoB sequencing; 6 of these were found to be
pulmonary cases of mixed NTM and M.TB infection [17]. A study
of clinical TB suspects in and around New Delhi found M. avium
and M.TB co-infection in 2.9% of an HIV-infected study
population [18]. In Zambia, the frequency of positive liquid
cultures for M.TB and NTM varied between 6 and 14% among a
hospital-based population of chronically ill adult patients, 75% of
them infected with HIV [19]. Thirty-one patients (17%) had NTM
isolated; of these, only one patient fulfilled the American Thoracic
Society criteria for NTM lung disease [19]. Based on these data, it
is evident that the frequency of NTM varies depending on the
geographic location and local epidemiology of NTM disease.
In regions where NTM prevalence is known to be high reliance
on ZN staining alone to identify MTB from growth on solid
culture media may lead to overtreatment of patients. It may also
lead to development of resistance since many NTM are partially
but incompletely responsive to standard MTB treatment.
Other organisms identified
Two of the organisms we identified have been infrequently
reported as causes of human disease. M. luteus is a commensal,
non-pathogenic organism found on mammalian skin and in soil
and environmental water sources. M. luteus infections are rare but
have been reported in patients with in-dwelling plastic medical
devices; they have also been reported in association with folliculitis
in patients with HIV-1 disease [20]. The Janibacter species
sequenced in this study most closely matched a recently described
marine Janibacter strain and aside from one case report involving
an immunocompromised host with an indwelling central venous
catheter, all isolation of Janibacter species has been from
environmental sources [21–22]. Given the clinical presentations
of the patients in this study and the generally non-pathogenic
nature of the two environmentally occurring microbes, it is likely
that M. luteus and Janibacter spp. cultured in this study are due to
contamination.
Our study has some limitations. First, we used a convenience
sample of HIV-infected patients receiving care in Mulago Hospital
in Kampala, which introduces potential bias as our sample may
not be representative of the general HIV-infected population.
Therefore, our findings may not be applicable to other populations
and geographic regions. Second, the initial cultures for mycobac-
teria were performed only on solid media, which has a low
recovery rate for NTM [23], but liquid culture systems were
unfortunately not in routine use at the Uganda NTRL at the time
of the study. Additional studies evaluating relevant populations of
tuberculosis suspects would help guide practice in laboratories
using liquid culture systems. Third, we cannot exclude the
possibility of co-infection with MTBC and NTM species in the 6
(11.5%) of 52 cultures in which the sequence result was not
available.
In summary, all of the patients in this study of HIV-infected
patients with cough of two weeks or more with a Lowenstein-
Jensen culture positive for mycobacteria in respiratory specimens
had tuberculosis. This finding suggests that routine speciation is
unnecessary in HIV-infected patients admitted to Mulago Hospital
with suspected pulmonary TB and positive LJ cultures. Future
studies using liquid culture systems and NTM-specific PCR assays
should be conducted to confirm our findings and to evaluate
further for the possibility that mixed infections are present.
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